| NCT00984399 | Atrophic Vaginitis|Breast Cancer | Drug: Vagifem庐 (vaginal 17尾-estradiol) questionnaire & menopause symptom checklist | Memorial Sloan Kettering Cancer Center | | 2009-09-01 | 2016-05-31 |
| NCT00698035 | Sexual Dysfunction, Physiological | Drug: Testosterone Cream|Drug: Estring | University of California, San Francisco | Phase 2 | 2007-03-01 | 2014-05-27 |
| NCT01753102 | Vulvar Atrophy|Vaginal Atrophy | Drug: Estradiol | Sun Pharmaceutical Industries Limited | Phase 3 | 2012-11-01 | 2015-05-19 |
| NCT00744328 | Postpartum Depression | Drug: Transdermal Estradiol|Drug: Sertraline|Other: Placebo | Northwestern University | Phase 4 | 2008-08-01 | 2014-10-20 |
| NCT01923298 | Estrogen Levels Among Breast Cancer Patients | Drug: Estradiol | University of Arizona | Phase 2 | 2013-08-09 | 2017-02-03 |
| NCT00741858 | Chiari Malformation | Procedure: Duragen duraplasty|Procedure: Duraguard duraplasty | University of Illinois at Chicago | Phase 3 | 2003-04-01 | 2015-07-08 |
| NCT01218386 | Infertility | Drug: Estradiol valerate | Universitair Ziekenhuis Brussel | Phase 4 | 2010-05-01 | 2012-03-27 |
| NCT02626208 | Suppression of Ovulation | Device: Nestorone庐/Estradiol Contraceptive Vaginal Ring | Health Decisions|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Phase 2 | 2016-01-01 | 2016-11-14 |
| NCT00870220 | Turner's Syndrome | Drug: Norditropin, Menostar 14mcg patch, Vivelle dot 25mcg patch | University of Chicago|Novo Nordisk A/S|University of Michigan|Johns Hopkins University|Massachusetts General Hospital|University of Oklahoma|University of South Florida|Thomas Jefferson University | Phase 1 | 2009-04-01 | 2014-03-10 |
| NCT01109979 | Cardiovascular Diseases | Drug: Estradiol+MPA|Drug: Estradiol+Drospirenone | Brigham and Women's Hospital|Bayer | Phase 4 | 2009-12-01 | 2016-06-10 |
| NCT00167648 | Cancer|Prostate Neoplasms | Drug: Leuprolide or goserelin|Drug: Transdermal estradiol | University of Washington|Pacific Northwest SPORE (Specialized Projects in Oncology Research Excellence) | Phase 2 | 2005-03-01 | 2009-01-15 |
| NCT00789802 | Contraception|Bleeding | Drug: transdermal estradiol|Drug: naproxen|Drug: oral placebo | Washington University School of Medicine|American College of Obstetricians and Gynecologists | | 2008-11-01 | 2014-12-08 |
| NCT00563576 | Metrorrhagia | Drug: Femring庐|Drug: DepoProvera 庐 | Columbia University | | 2007-09-01 | 2012-12-11 |
| NCT02792153 | Anorexia Nervosa | Drug: Estradiol | Johns Hopkins University | Phase 1 | 2016-12-01 | 2016-12-12 |
| NCT01779947 | Atrophic Vaginitis Due to Menopause | Drug: Estradiol Vaginal Tablets 10 mcg|Drug: placebo | Amneal Pharmaceuticals, LLC | Phase 3 | 2012-03-01 | 2014-06-25 |
| NCT02238808 | Estrogen Receptor Positive Breast Cancer | Drug: Estradiol | AHS Cancer Control Alberta | Phase 2 | 2015-08-01 | 2017-01-04 |
| NCT02485821 | Failed Induction of Labor | Drug: Estradiol|Drug: Placebo|Drug: Misoprostol | Ain Shams University | Phase 2|Phase 3 | 2015-06-01 | 2016-02-14 |
| NCT00775242 | Menopause | Drug: Estradiol and Progesterone|Drug: Estradiol and Progesterone | Centro A.F. de Estudios Tecnologicos, S.A. | Phase 2|Phase 3 | 2007-04-01 | 2009-08-21 |
